Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;10(5):444-451.
doi: 10.1016/j.jpha.2020.09.003. Epub 2020 Sep 18.

Fluorescent antibiotics for real-time tracking of pathogenic bacteria

Affiliations
Review

Fluorescent antibiotics for real-time tracking of pathogenic bacteria

Lu Miao et al. J Pharm Anal. 2020 Oct.

Abstract

The harm of pathogenic bacteria to humans has promoted extensive research on physiological processes of pathogens, such as the mechanism of bacterial infection, antibiotic mode of action, and bacterial antimicrobial resistance. Most of these processes can be better investigated by timely tracking of fluorophore-derived antibiotics in living cells. In this paper, we will review the recent development of fluorescent antibiotics featuring the conjugation with various fluorophores, and focus on their applications in fluorescent imaging and real-time detection for various physiological processes of bacteria in vivo.

Keywords: Fluorescent antibiotics; Fluorescent imaging; Fluorophore; Live-cell tracking; Pathogenic bacteria.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Structure of various antibiotics and fluorophores. NBD: nitrobenzofurazan, DMACA: 7-(dimethylamino)-coumarin-4-acetic acid, BODIPY: dansyl,boron-dipyrromethene.
Fig. 2
Fig. 2
Super resolution imaging with different fluorescent antibiotics. (A) Structure of NBD-derived fluorescent antibiotic 4C-Tz-NBD [47]. SR-SIM fluorescence imaging of (B) S. aureus, (C) wild type E. coli, and (D) ΔtolC E. coli. And cross section of fluorescent imaging of (E) wild type E. coli and (F) ΔtolC E. coli: green, 4C-Tz-NBD; red, FM4-64FX; blue, Hoechst 33342. (G) Structures of fluorescent antibiotics Boc-FL and Ceph C-T [76]. 3D-SIM super-resolution microscope imaging of (H) B. subtilis and (I) S. pneumoniae IU 1945 PBPs after dual labeling with Ceph C-T (red) and Boc-FL (green) in live cells. NBD: nitrobenzofurazan, SR-SIM: super-resolution structured illumination microscopy, PBPs: penicillin-binding proteins.
Fig. 3
Fig. 3
(A) Near-infrared fluorescent antibiotic vanco-800CW [39] and (B) its real-time imaging of bacterial infections in living mice. Left side: bioluminescence imaging; right side: fluorescence imaging (excitation 745 nm, emission 840 nm).
Fig. 4
Fig. 4
Schematic representation of ratiometric signal generation process of CCF2 probe while degrated by β-Lactamase.

Similar articles

Cited by

References

    1. Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543:15. - PubMed
    1. Jones K.E., Patel N.G., Levy M.A. Trends in emerging infectious diseases. Nature. 2008;451:990–993. - PMC - PubMed
    1. Alekshun M.N., Levy S.B. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128:1037–1050. - PubMed
    1. Piddock L.J.V. Reflecting on the final report of the O’Neill review on antimicrobial resistance. Lancet Infect. Dis. 2016;16:767–768. - PubMed
    1. Payne D.J., Gwynn M.N., Holmes D.J. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 2007;6:29–40. - PubMed

LinkOut - more resources